Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Olivier Lesueur
Authored Items
Immuno-Oncology Brings New Opportunities for Developers of Targeted Cytotoxics
By
Rachel Laing, PhD
;
Olivier Lesueur
September 2015, Vol. 2, No. 5
Editorial
Read More ›
The Commercialization Process of Immunotherapies:
An Interview with Olivier Lesueur and Rachel Laing, PhD
By
Olivier Lesueur
May 2015, Vol. 2, No. 3
Interview with the Innovators
Read More ›